Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.5 |